Search Results 331-340 of 16722 for Imiglucerase
About this study. Evaluate the safety, tolerability, and efficacy of 28 days of treatment with ALLN-177 for reducing urinary oxalate excretion in patients ...
This is a peripheral blood Collection Protocol to study the T-cell immune responses of patients with malignancies displaying one of three different patterns ...
This study will examine the effect intravenously administered rigosertib has on the relationship between bone marrow blasts response and overall survival in ...
The purpose of this study is to investigate the safety and tolerability of a single intravenous (IV) dose of SGT-501. Participation eligibility. Participant ...
Early diagnosis of nerve root avulsion injuries following brachial plexus trauma remain a barrier to the early treatment of these complex injuries.
Chronic high blood sugar can lead to serious health problems in the future. Proper diet is the first step in managing type 2 diabetes but often medicines are ...
Charles J. Bruce, M.B., Ch.B., a Mayo Clinic cardiologist, develops technologies that expand how cardiovascular care is delivered.
Explore services for a healthy lifestyle, early disease detection, preventive strategies and diagnosis of adults with unexplained symptoms.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.